-
Posted by
Two Blokes Jul 17 -
Filed in
Stock
-
4 views
PHILADELPHIA, July 17, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC , a Philadelphia-based law firm focused on investor protection, is investigating claims against Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket Pharmaceuticals” or the “Company”) for potential violations of federal securities laws. A class action has been filed over allegations that the Company concealed safety concerns tied to its RP-A501 trial, leading to steep investor losses.
